Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Erik Uhlmann"'
Publikováno v:
Thursday, April 27.
Autor:
Bijaya Thapa, Azma Mareyam, Jason Stockmann, Bernhard Strasser, Boris Keil, Philipp Hoecht, Stefan A. Carp, Xianqi Li, Zhe Wang, Yulin V. Chang, Jorg Dietrich, Erik Uhlmann, Daniel P. Cahill, Tracy Batchelor, Lawrence Wald, Ovidiu C. Andronesi
Publikováno v:
Journal of Magnetic Resonance Imaging. 56
Autor:
Sirui Ma, Rushad Patell, Eric Miller, Siyang Ren, Josue Marquez-Garcia, Samuel Panoff, Ria Sharma, Amanda Pinson, Pavania Elavalakanar, Griffin Weber, Erik Uhlmann, Donna Neuberg, Salil Soman, Jeffrey I. Zwicker
Publikováno v:
Blood. 140:2819-2820
Autor:
Fabio Iwamoto, Shyam Tanguturi, Arati Desai, Lakshmi Nayak, Erik Uhlmann, Tony Wang, Robert Lustig, Lauren Hertan, Stephen Bagley, Julia Hayden, Corey Laforest-Roys, Alona Muzikansky, Christine McCluskey, Ugonma Chukwueke, J Ricardo McFaline-Figueroa, Eudocia Lee, Patrick Y Wen, David Reardon
Publikováno v:
Neuro-Oncology. 24:vii63-vii64
Re-irradiation is therapeutically considered for select rGBM patients and may induce immunogenic cell death to stimulate anti-tumor immune responses. Our phase 2 study of re-irradiation with pembrolizumab among rGBM patients evaluated the efficacy an
Publikováno v:
Radiotherapy and Oncology. 174:S17-S18
Autor:
Bijaya Thapa, Azma Mareyam, Jason Stockmann, Bernhard Strasser, Boris Keil, Philipp Hoecht, Stefan A. Carp, Xianqi Li, Zhe Wang, Yulin V. Chang, Jorg Dietrich, Erik Uhlmann, Daniel P. Cahill, Tracy Batchelor, Lawrence Wald, Ovidiu C. Andronesi
Publikováno v:
J Magn Reson Imaging
BACKGROUND: Absolute quantification of metabolites in MR spectroscopic imaging (MRSI) requires a stable reference signal of known concentration. The Electronic REference To access In vivo Concentrations (ERETIC) has shown great promise but has not be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::261875048e473d45fc1a4635f90a3c9d
https://europepmc.org/articles/PMC9189023/
https://europepmc.org/articles/PMC9189023/
Autor:
David A. Reardon, Laszlo Mechtler, Ahmed Belal, Robert A. Fenstermaker, Manmeet Ahluwalia, Ajay Abad, David M. Peereboom, Eric T. Wong, Michael J. Ciesielski, Danielle Casucci, Jingxin Qiu, Cathy Schilero, Erik Uhlmann, William T. Curry, Kathleen Mogensen
Publikováno v:
Neuro-Oncology. 20:vi10-vi11
BACKGROUND: Survivin is an anti-apoptotic protein that is highly expressed in glioblastoma (GBM). We conducted a single-arm, multi-center phase II trial in newly diagnosed GBM (nGBM) to determine 6-month progression-free survival (PFS-6), 12-month ov
Techn. Univ., Diss.--Ilmenau, 2003.
Literaturverz. S. 89 - 95.
Literaturverz. S. 89 - 95.
Externí odkaz:
http://www.gbv.de/dms/ilmenau/abs/366795104roman.txt
http://www.gbv.de/dms/ilmenau/toc/364157070.PDF
http://www.gbv.de/dms/ilmenau/toc/364157070.PDF